September 2004, Dean Baker

Rising prescription drug prices are taking a toll on American families and on the greater economy. This paper explores four alternatives to patent-financed prescription drug research and compares their efficiency.

Report pdf_small

Press Release


GuideStar Exchange Gold charity navigator LERA cfc IFPTE

contact us

1611 Connecticut Ave., NW
Suite 400
Washington, DC 20009
(202) 293-5380
info@cepr.net

let's talk about it

Follow us on Twitter Like us on Facebook Follow us on Tumbler Connect with us on Linkedin Watch us on YouTube Google+ feed cepr.net rss feed